Frank Fischer
Founder at NEUROPACE, INC.
Net worth: 8 M $ as of 2024-04-29
Profile
Frank M.
Fischer is the founder of NeuroPace, Inc. (founded in 1997) and currently holds the title of Chairman.
He is also currently serving as Chairman at TherOx, Inc. since 1997.
Additionally, Mr. Fischer is a Director at Proteus Digital Health, Inc., the Epilepsy Foundation, and a Trustee at Rensselaer Polytechnic Institute.
In his former positions, Mr. Fischer served as President, Chief Executive Officer & Director at Ventritex, Inc. from 1987 to 1997.
He also held the same positions at Heartport, Inc. from 1998 to 1999.
Mr. Fischer was the Chairman & Chief Executive Officer at Aruene Corp.
and Chairman at Autonomic Technologies, Inc. He served as an Independent Director at TENON Medical, Inc. from 2022 to 2023 and as a Director at Leptos Biomedical, Inc. and Avertix Medical Systems, Inc. Mr. Fischer was an Independent Director at Nevro Corp.
from 2012 to 2024.
He was the President-Implantable Products Division at Cordis Corp.
from 1977 to 1987 and worked as a Principal at GE Aerospace.
Mr. Fischer also served as an Advisor at Aphelion Capital LLC.
Mr. Fischer received his undergraduate and graduate degrees from Rensselaer Polytechnic Institute.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEUROPACE, INC.
2.00% | 2023-06-06 | 565,657 ( 2.00% ) | 7 M $ | 2024-04-29 |
NEVRO CORP.
0.16% | 2024-03-30 | 57,500 ( 0.16% ) | 668 150 $ | 2024-04-29 |
Frank Fischer active positions
| Companies | Position | Start |
|---|---|---|
| NEUROPACE, INC. | Founder | 1997-11-30 |
| Rensselaer Polytechnic Institute | Director/Board Member | - |
| Babson College | Director/Board Member | - |
Epilepsy Foundation
 Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Director/Board Member | - |
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Director/Board Member | - |
TherOx, Inc.
 TherOx, Inc. Medical SpecialtiesHealth Technology TherOx, Inc. operates as a medical device company which focuses on developing and commercializing therapies to treat ischemic and oxygen deprived tissue. Its SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge that controls cartridge operation wherein SSO2 solution is created and mixed with the patient's blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded by David B. Musket, Paul J. Zalesky and J. Richard Spears in 1994 and is headquartered in Irvine, CA. | Chairman | 1997-11-30 |
Former positions of Frank Fischer
| Companies | Position | End |
|---|---|---|
| NEVRO CORP. | Director/Board Member | 2024-05-22 |
| TENON MEDICAL, INC. | Director/Board Member | 2023-11-29 |
Leptos Biomedical, Inc.
 Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use. | Director/Board Member | 2010-11-11 |
| ░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Frank Fischer
| Rensselaer Polytechnic Institute | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| GE AEROSPACE | Producer Manufacturing |
| NEVRO CORP. | Health Technology |
| NEUROPACE, INC. | Health Technology |
| TENON MEDICAL, INC. | Health Services |
| Private companies | 11 |
|---|---|
Heartport, Inc.
 Heartport, Inc. Medical SpecialtiesHealth Technology Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA. | Health Technology |
Aruene Corp.
 Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Health Technology |
TherOx, Inc.
TherOx, Inc. Medical SpecialtiesHealth Technology TherOx, Inc. operates as a medical device company which focuses on developing and commercializing therapies to treat ischemic and oxygen deprived tissue. Its SSO2 therapy consists of TherOx DownStream system, a mobile hardware device that interfaces with the TherOx DownStream Cartridge that controls cartridge operation wherein SSO2 solution is created and mixed with the patient's blood to create superoxygenated blood for delivery to the coronary arteries. The company was founded by David B. Musket, Paul J. Zalesky and J. Richard Spears in 1994 and is headquartered in Irvine, CA. | Health Technology |
Leptos Biomedical, Inc.
Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Leptos is developing a proprietary neuromodulation therapy for chronic obesity. The treatment, delivered via a pacemaker-type device, involves electrical activation of a specific nerve in the autonomic nervous system. They believe that this therapy may offer an effective minimally invasive, reversible surgical option for people suffering from chronic obesity. As yet, the Leptos therapy is not approved for sale in the United States and is limited to investigational use. | Health Technology |
Aphelion Capital LLC
 Aphelion Capital LLC Investment ManagersFinance Aphelion Capital LLC (Aphelion Capital) is a venture capital firm founded in 2005 by Ned Scheetz and Rodney Altman. The firm is headquartered in Mill Valley, California. | Finance |
Ventritex, Inc.
 Ventritex, Inc. Medical SpecialtiesHealth Technology Ventritex, Inc. designs, develops, manufactures and markets implantable defibrillators and related products for the treatment of ventricular tachycardia and ventricular fibrillation. | Health Technology |
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Avertix Medical Systems, Inc.
 Avertix Medical Systems, Inc. Medical DistributorsDistribution Services Avertix Medical Systems, Inc. develops and markets cardiac medical devices. Its product allows to reduce time to treatment and minimize heart muscle damage The company was founded by Robert E. Fischell, Tim A. Fischell and David R. Fischell in 2001 and is headquartered in Shrewsbury, NJ. | Distribution Services |
Autonomic Technologies, Inc.
 Autonomic Technologies, Inc. Electronic Equipment/InstrumentsElectronic Technology Autonomic Technologies, Inc. develops and commercializes innovative therapies for the treatment of severe headache. Its product, the ATI Neurostimulation System, is used for the treatment of acute pain of cluster headache. The company was founded in 2007 and is headquartered in Redwood City, CA. | Electronic Technology |
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Health Technology |
Epilepsy Foundation
Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Commercial Services |
- Stock Market
- Insiders
- Frank Fischer
